Publicaciones en las que colabora con DAVID NAVARRO ORTEGA (18)

2024

  1. Role of the first WHO mutation catalogue in the diagnosis of antibiotic resistance in Mycobacterium tuberculosis in the Valencia Region, Spain: a retrospective genomic analysis

    The Lancet Microbe, Vol. 5, Núm. 1, pp. e43-e51

2022

  1. Population-based sequencing of Mycobacterium tuberculosis reveals how current population dynamics are shaped by past epidemics

    eLife, Vol. 11

2021

  1. Accuracy of an amplicon-sequencing nanopore approach to identify variants in tuberculosis drug-resistance-associated genes

    Microbial genomics, Vol. 7, Núm. 12

2020

  1. Clinical significance of Pneumocystis jirovecii DNA detection by real-time PCR in hematological patient respiratory specimens

    Journal of Infection

  2. Field performance of the Abbott RealTime MTB assay for the diagnosis of extrapulmonary tuberculosis in a low-prevalence setting

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 5, pp. 206-211

  3. Whole-genome sequencing of Mycobacterium tuberculosis directly from clinical samples for high-resolution genomic epidemiology and drug resistance surveillance: an observational study

    The Lancet Microbe, Vol. 1, Núm. 4, pp. e175-e183

2019

  1. Evaluation of the DNA microarray “AMR Direct Flow Chip Kit” for detection of antimicrobial resistance genes from Gram-positive and Gram-negative bacterial isolated colonies

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 37, Núm. 7, pp. 454-457

  2. Incidence, risk factors, and outcome of pulmonary invasive fungal disease after respiratory virus infection in allogeneic hematopoietic stem cell transplantation recipients

    Transplant Infectious Disease, Vol. 21, Núm. 5

2018

  1. Performance of a highly sensitive mycobacterium tuberculosis complex real-time PCR assay for diagnosis of pulmonary tuberculosis in a low-prevalence setting: a prospective intervention study

    Journal of Clinical Microbiology, Vol. 56, Núm. 5

2017

  1. Neumonía familiar grave con aislamiento de Streptococcus pneumoniae

    Revista de Patologia Respiratoria

2016

  1. Performance characteristics of the new Abbott Real Time MTB assay for detection of Mycobacterium tuberculosis complex in respiratory specimens

    Diagnostic Microbiology and Infectious Disease, Vol. 84, Núm. 3, pp. 212-214

2015

  1. Epidemiology of invasive candidiasis in a surgical intensive care unit: an observational study

    BMC Research Notes, Vol. 8, Núm. 1

2013

  1. Frequent detection of cytomegalovirus (CMV) DNA in the lower respiratory tract in CMV-seropositive pediatric patients with underlying chronic bronchopulmonary diseases lacking canonical immunosuppression

    Journal of Medical Virology, Vol. 85, Núm. 5, pp. 888-892

2012

  1. Prevalence of Trypanosoma cruzi infection in pregnant Latin American women and congenital transmission rate in a non-endemic area: The experience of the Valencian Health Programme (Spain)

    Epidemiology and Infection, Vol. 140, Núm. 10, pp. 1896-1903

2011

  1. Achalasia and mycobacterium goodii pulmonary infection

    Pediatric Infectious Disease Journal, Vol. 30, Núm. 5, pp. 447-448

  2. Diagnostic accuracy and potential clinical value of the LightCycler SeptiFast assay in the management of bloodstream infections occurring in neutropenic and critically ill patients

    International Journal of Infectious Diseases, Vol. 15, Núm. 5

  3. Performance of the lightCycler septiFast test M grade in detecting microbial pathogens in purulent fluids

    Journal of Clinical Microbiology, Vol. 49, Núm. 8, pp. 2988-2991

2010

  1. Positive result of the Aspergillus galactomannan antigen assay using bronchoalveolar lavage fluid from a patient with an invasive infection due to Lichtheimia ramosa

    Journal of Clinical Microbiology